Guan, Yelan
Gu, Xiaodong
Si, Jinfei
Xiang, Jing
Wei, Jingwen
Hao, Yue
Wang, Wenxian
Sun, Yan
Article History
Received: 4 September 2022
Accepted: 14 December 2022
First Online: 5 January 2023
Declarations
:
: The study protocol was approved by the Institutional Ethics Committee of Zhejiang Cancer Hospital (approval number: IRB-2022-62). Due to the retrospective study design, the ethics committee of Ethics Committee of Zhejiang Cancer Hospital approved a waiver of written informed consent. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors have no relevant interests to disclose.